S
Simulations Plus
Providing software and consulting to accelerate drug discovery and development
At a glance
- Status
- Listed
- Founded
- 1996
- Headquarters
- Durham, United States
- Listing
- IPO 1997
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
Investments and acquisitions
Disclosed deals where Simulations Plus was the backer or acquirer, 2014–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
6 deals across Simulations Plus's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Simulations Plus's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Simulations Plus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Simulations Plus on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.